COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

New Blood: Lab-Grown Stem Cells Bode Well for Transplants, Aging Research

 

August 12, 2021  |  

Hematopoietic stem cells — the precursors to blood cells — have been notoriously difficult to grow in a dish, a critical tool in basic research. Scientists at University of California San Diego School of Medicine have identified the underlying issue and developed a method to keep cultured cells healthy. These findings, they say, are positive news for patients seeking stem cell transplants — and may hint at a new way to ward off aging.

The findings published in the August 12, 2021 online issue of Cell Stem Cell.

In bone marrow transplants, hematopoietic stem cells are infused intravenously to reestablish blood production in patients whose bone marrow or immune system is damaged. The procedure is used to treat diseases such as leukemia, lymphoma, aplastic anemia and immune deficiency disorders. However, donor stem cells are not always available for patients who need them.

HSF1 graphic

The HSF1-mediated heat shock pathway promotes proteostasis in hematopoietic stem cells in culture and during aging. Photo credit: Cell Press

“Even for patients who do receive stem cell therapies, transplanting more cells yields fewer complications and increases chances of overarching success,” said senior author Robert Signer, PhD, assistant professor of medicine at UC San Diego School of Medicine.

While other researchers have tried to culture hematopoietic stem cells by recreating the bone marrow environment in a dish, Signer’s team instead asked what internal mechanism makes the cells unhealthy to begin with, and could they remedy that process directly?

Lead author Miriama Kruta, PhD, postdoc in Signer's lab at the time of the study, and colleagues found that in the foreign environment of the culture dish, stem cells begin producing excess proteins, causing extreme stress. The state of stress activates the heat shock response, a highly conserved stress reduction pathway regulated by heat shock factor 1 (HSF1). The researchers identified two different small molecules that super-activate the HSF1 gene. By adding these to the culture, the enhanced activity of the heat shock pathway helped rebalance the cells’ state of equilibrium or homeostasis.

“Now, we can preserve high-quality stem cells in culture over a prolonged period of time,” said Signer. “We hope the increased quality will lead to improved clinical outcomes.”

The recovery of protein homeostasis by enhanced HSF1 activation was shown in both mouse and human hematopoietic stem cells. The next step, said Signer, is to test how these small molecules affect the outcome of human stem cells in transplantation systems.

The researchers discovered the heat shock pathway isn’t just important in a Petri dish, it also keeps stem cells healthy in their native bone marrow during aging. While HSF1 is inactive in the stem cells of young adults, it is turned on in middle-aged and older adults.

HSF1 is activated during aging to keep your stem cells fit,” said Signer. “Protein damage impairs stem cells during aging and likely contributes to disrupting blood and immune cell production in older people.” Signer said super-activating HSF1 might eventually be used to improve stem cell and tissue function in aging to prevent blood disorders and boost immunity in older adults.

Co-authors of the study include: Mary Jean Sunshine, Bernadette A. Chua, Yunpeng Fu, Christopher H. Dillingham, Lorena Hidalgo San Jose, Bijou De Jong and Fanny J. Zhou, all at UC San Diego; and Ashu Chawla at the La Jolla Institute of Immunology.

Funding for this research came, in part, from the National Institutes of Health (grants R01DK116951, R01DK124775, S10 RR027366, P30CA023100), the Blood Cancer Discoveries Grant program (8025-20) through The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research, The Paul G. Allen Frontiers Group, Scholar Awards from the V Foundation for Cancer Research (V2017-003) and the American Society of Hematology, and the Sanford Stem Cell Clinical Center.




Media Contact

Nicole Mlynaryk, Bigelow Science Communication Fellow
858-249-0456
npmlynaryk@health.ucsd.edu

Share This Article


Related News

7/6/2021
University of California San Diego School of Medicine researchers identified a possible link between inadequate exposure to ultraviolet-B (UVB) light from the sun and an increased risk of colorectal c ...
5/20/2019
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need ...
12/3/2018
Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Di ...
8/26/2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and l ...



Follow Us